Literature DB >> 3606681

Quantitative pain assessment for routine care of rheumatoid arthritis patients, using a pain scale based on activities of daily living and a visual analog pain scale.

L F Callahan, R H Brooks, J A Summey, T Pincus.   

Abstract

Pain was assessed quantitatively as a component of routine visits of 385 outpatients with rheumatoid arthritis, using a pain scale based on activities of daily living (ADL) and a visual analog scale. The ADL pain scale met psychometric criteria for validity and reliability. Scores on the 2 pain scales were correlated significantly with one another and with other measures of disease status, including joint count, grip strength, walking time, button test, morning stiffness, erythrocyte sedimentation rate, global self-assessment, ADL difficulty, and ADL dissatisfaction scales. Correlations of ADL pain scale scores with other measures were higher than were correlations of visual analog scale scores with other measures, in both unadjusted and adjusted analyses. Significantly more patients completed the ADL pain scale without assistance than the number of those who completed the visual analog pain scale. The ADL pain scale was more sensitive to problems in ADL than were the ADL scales for difficulty and dissatisfaction. The ADL and visual analog pain scales appear to provide useful data for quantitative assessment of pain in the routine care of rheumatoid arthritis patients.

Entities:  

Mesh:

Year:  1987        PMID: 3606681     DOI: 10.1002/art.1780300605

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  13 in total

Review 1.  Impairment measures in rheumatic disorders for rehabilitation medicine and allied health care: a systematic review.

Authors:  Raymond A H M Swinkels; Lex M Bouter; Rob A B Oostendorp; Cornelia H M van den Ende
Journal:  Rheumatol Int       Date:  2005-06-24       Impact factor: 2.631

2.  [Clinical diagnosis and documentation of chronic-rheumatic pain syndromes the state of the art 1990.].

Authors:  H H Raspe; T Kohlmann
Journal:  Schmerz       Date:  1991-03       Impact factor: 1.107

3.  Comparison of conditional quality of life terminology and visual analogue scale measurements.

Authors:  S M Grunberg; S Groshen; S Steingass; S Zaretsky; B Meyerowitz
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

4.  A randomized trial of three psychosocial treatments for the symptoms of rheumatoid arthritis.

Authors:  Arthur J Barsky; David K Ahern; E John Orav; Yvonne Nestoriuc; Matthew H Liang; Ilana T Berman; Joshua R Kingsbury; Jennifer T Sy; Kathryn G Wilk
Journal:  Semin Arthritis Rheum       Date:  2010-12       Impact factor: 5.532

5.  A contrasting view on rheumatoid arthritis.

Authors:  L F Callahan; T Pincus; F Wolfe
Journal:  Am J Public Health       Date:  1989-09       Impact factor: 9.308

Review 6.  The underestimated long term medical and economic consequences of rheumatoid arthritis.

Authors:  T Pincus
Journal:  Drugs       Date:  1995       Impact factor: 9.546

7.  Effects of an educational-behavioral joint protection program on people with moderate to severe rheumatoid arthritis: a randomized controlled trial.

Authors:  Stefano Masiero; Anna Boniolo; Lidia Wassermann; Hela Machiedo; Daniela Volante; Leonardo Punzi
Journal:  Clin Rheumatol       Date:  2007-04-03       Impact factor: 2.980

8.  Mindfulness meditation alleviates fibromyalgia symptoms in women: results of a randomized clinical trial.

Authors:  Elizabeth Cash; Paul Salmon; Inka Weissbecker; Whitney N Rebholz; René Bayley-Veloso; Lauren A Zimmaro; Andrea Floyd; Eric Dedert; Sandra E Sephton
Journal:  Ann Behav Med       Date:  2015-06

9.  Validation and relevance of Rheumatoid Arthritis Pain Scale (RAPS) in Indian (Asian) patients suffering from rheumatoid arthritis.

Authors:  Toktam Kianifard; Taghi Kianyfard; Arvind Chopra
Journal:  Clin Rheumatol       Date:  2015-09-12       Impact factor: 2.980

10.  Evaluation of outpatient experience with vitreoretinal surgery.

Authors:  C S Cannon; J G Gross; I Abramson; W J Mazzei; W R Freeman
Journal:  Br J Ophthalmol       Date:  1992-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.